Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation.
about
Extracellular Vesicles: A New Frontier in Biomarker Discovery for Non-Alcoholic Fatty Liver DiseaseCirculating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular CarcinomaExosomes as potent regulators of HCC malignancy and potential bio-tools in clinical applicationCirculating MicroRNAs: A Next-Generation Clinical Biomarker for Digestive System CancersBioinformatic Interrogation of 5p-arm and 3p-arm Specific miRNA Expression Using TCGA DatasetsExosomal microRNA in plasma as a non-invasive biomarker for the recurrence of non-small cell lung cancer.Extracellular vesicles: potential applications in cancer diagnosis, prognosis, and epidemiology.Exosomes in cancer: small particle, big player.Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancerA microRNA biomarker of hepatocellular carcinoma recurrence following liver transplantation accounting for within-patient heterogeneity.Identification of Recurrence-Related microRNAs from Bone Marrow in Hepatocellular Carcinoma Patients.Exosomal microRNA Biomarkers: Emerging Frontiers in Colorectal and Other Human Cancers.Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation.Plasma exosome microRNAs are indicative of breast cancer.Involvement of microRNA-718, a new regulator of EGR3, in regulation of malignant phenotype of HCC cells.Exosomes: small vesicles with big roles in hepatocellular carcinoma.Functional Roles and Therapeutic Applications of Exosomes in Hepatocellular Carcinoma.Specific circulating microRNA signature of bicuspid aortic valve disease.Cell-derived extracellular vesicles as a platform to identify low-invasive disease biomarkers.Non-Coding RNAs in Primary Liver Cancer.Emerging techniques in the isolation and characterization of extracellular vesicles and their roles in cancer diagnostics and prognostics.Liquid Biopsy and its Potential for Management of Hepatocellular Carcinoma.Exosomes in liver pathology.Genome-wide identification of differential methylation between primary and recurrent hepatocellular carcinomas.Extracellular miRNAs as biomarkers in cancer.Exosomes: novel implications in diagnosis and treatment of gastrointestinal cancer.MicroRNAs in extracellular vesicles: potential cancer biomarkers.Emerging role of exosomes in liver physiology and pathology.Exosomal miRNAs as biomarkers in the diagnosis of liver disease.Exosomes: New players in cancer (Review).Extracellular vesicles in liver disease and potential as biomarkers and therapeutic targets.Cell-based therapy using miR-302-367 expressing cells represses glioblastoma growth.Hepatocellular carcinoma beyond Milan criteria: Management and transplant selection criteria.Exosomal miR-665 as a novel minimally invasive biomarker for hepatocellular carcinoma diagnosis and prognosis.Exosomal microRNAs as potential circulating biomarkers in gastrointestinal tract cancers: a systematic review protocol.Circulating exosomal microRNA-203 is associated with metastasis possibly via inducing tumor-associated macrophages in colorectal cancer.Placental exosomes: A proxy to understand pregnancy complications.Extracellular vesicles: Novel mediator for cell to cell communications in liver pathogenesis.Role of exosomes and exosomal microRNAs in hepatocellular carcinoma: Potential in diagnosis and antitumour treatments (Review).Exosomal miRNAs in hepatocellular carcinoma development and clinical responses.
P2860
Q26764843-EC17DDF3-4D38-49F0-A6C0-007D291144DBQ26767346-D2D50BF9-480F-45EC-97D7-D760AF80A28EQ26771839-53CB9055-F680-4BD8-B85F-991C339EB8BAQ28080153-42B06DDB-E0E1-4F0D-9491-CF950F45437FQ30488342-5D816D09-DF05-46AE-9A15-F01E2FE60339Q33598531-9B4EBA4A-BB77-40B2-BBFA-DC463A1EE17CQ35440744-9FADE45A-AF1D-4238-B43E-8D2361B5F47EQ35834473-66A17831-7AA4-4F1F-BC49-33AAC04D1547Q35863159-AD44B0D3-B04B-44DA-82F6-F2C7C3F69AF8Q35984012-F7F7760C-D86A-4932-AB9D-8D8AA269CB85Q36012203-F342455D-EB06-4630-8AA5-E491CC3415F9Q37073022-5FC59C24-ABC1-430F-A26E-AF48FE1DF20BQ37190186-DD5FB741-63C2-43F7-A420-B720E87925C4Q37243591-D3A0DDB6-85F2-4121-88DD-318F2493A867Q37602841-BA747E74-98F0-4633-AEF5-FE5E6466081EQ37645086-39FA1C22-5A1B-419D-84EF-372E1A948267Q37654423-CC6F5061-3549-4DDC-8541-E30FBCD9FADCQ37747621-DF156A2C-DBDC-41BE-BCE1-A312D2AC8C58Q38463053-A1298903-2571-4394-9A32-0030D9414717Q38541359-BFA691E1-C026-4E80-9D58-8D7D5CC24361Q38624837-D42309DC-5C48-4910-B774-90A37D6D0CC5Q38770935-7F9CFC3A-C628-4AE2-99FB-70EBBB39B767Q38779087-FB93BBAE-8A95-479B-AA37-50421C08E686Q38857159-52430FB6-C70C-4CD5-B858-AE633FD871C2Q38867417-6487D241-F09E-4DD9-B285-B2D695C9CD0EQ38876434-D8ADEF7C-F446-4E90-8672-D2578E473672Q38887851-9F2D63BD-2470-44B8-9B6D-E52A4DE0CE20Q38931228-DDF3127F-8998-49F1-BE3F-0E4D375397A9Q39361895-644242EC-2B6C-428E-9EDE-56C5E9F06B12Q39382436-D3F688F6-FC6B-49C4-BE39-C7527B7CE229Q39387022-FB8B95F4-7F99-418F-98DA-0D2B384D22EEQ41959565-47AD7E55-F78C-42B0-9749-714B7A4CF18DQ42256347-32CFEB71-445A-4E75-8A74-5625C538D523Q47109252-734B0DCD-10DE-46D2-983F-2F1F57FBBE1FQ47109593-8796916E-8194-40AD-80BC-7A75FDE80594Q47136104-845CE372-E742-469B-8FA0-22A2E2249A4EQ47343430-563503DF-D867-4400-867E-B7EB669175BFQ47419610-32E9BF73-507B-4637-A23C-B25CFFCF4296Q50067800-E752AE4E-B160-4E35-88D4-3740A17E28F6Q52593381-A31FE390-7A46-4073-98A1-C1BB72D6C93D
P2860
Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Identification of a bona fide ...... e after liver transplantation.
@ast
Identification of a bona fide ...... e after liver transplantation.
@en
type
label
Identification of a bona fide ...... e after liver transplantation.
@ast
Identification of a bona fide ...... e after liver transplantation.
@en
prefLabel
Identification of a bona fide ...... e after liver transplantation.
@ast
Identification of a bona fide ...... e after liver transplantation.
@en
P2093
P2860
P921
P356
P1476
Identification of a bona fide ...... e after liver transplantation.
@en
P2093
K Sugimachi
T Matsumura
P2860
P2888
P304
P356
10.1038/BJC.2014.621
P407
P577
2015-01-13T00:00:00Z